Persistence of the neutralizing antibody response one year after a single injection of a new Yellow fever vaccine in adults

被引:0
|
作者
Feroldi, Emmanuel [1 ]
Mulligan, Mark J. [1 ]
Talaat, Kawsar [1 ]
Tan, Chen Sabrina [1 ]
Paolino, Kristopher [1 ]
Edupuganti, Srilatha [1 ]
Collins, Matthew H. [1 ]
George, Sarah L. [1 ]
Davis, Matthew [1 ]
Essink, Brandon [1 ]
Peterson, James [1 ]
Fried, David [1 ]
Valero, Natalia Rodriguez [1 ]
Ramharter, Michael [1 ]
Launay, Odile [1 ]
Kantele, Anu [1 ]
Tantawichien, Terapong [1 ]
Low, Jenny Guek-Hong [1 ]
Orlando, Sandrine [1 ]
Davaux, Pascale [1 ]
Machabert, Tifany [1 ]
Dufournet, Marine [1 ]
Devlin, Louis [1 ]
Frago, Carina [1 ]
机构
[1] Sanofi, Lyon, France
关键词
D O I
10.1016/j.ijid.2024.107447
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Seroconversion and persistence of neutralizing antibody response after yellow fever vaccination in patients with perinatally acquired HIV infection
    Martin, Charlotte
    Domingo, Cristina
    Hainaut, Marc
    Delforge, Marc
    De Wit, Stephane
    Dauby, Nicolas
    AIDS, 2023, 37 (02) : 341 - 346
  • [2] Neutralizing antibody response to booster vaccination with the 17d yellow fever vaccine
    Hepburn, MJ
    Kortepeter, MG
    Pittman, PR
    Boudreau, EF
    Mangiafico, JA
    Buck, PA
    Norris, SL
    Anderson, EL
    VACCINE, 2006, 24 (15) : 2843 - 2849
  • [3] PERSISTENCE OF NEUTRALIZING ANTIBODY 30-35 YEARS AFTER IMMUNIZATION WITH 17D YELLOW-FEVER VACCINE
    POLAND, JD
    CALISHER, CH
    MONATH, TP
    DOWNS, WG
    MURPHY, K
    BULLETIN OF THE WORLD HEALTH ORGANIZATION, 1981, 59 (06): : 895 - 900
  • [4] Persistence of neutralizing antibodies after one injection of monovalent Chimerivax™ dengue 2 vaccine
    Forrat, Remi
    Morrison, Dennis
    Kanesa-Thasan, Niranjan
    Guirakhoo, Farshad
    Yoksan, Sutee
    Monath, Thomas
    Lang, Jean
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2005, 73 (06): : 220 - 220
  • [5] A 5-year neutralizing immune response to yellow fever vaccine in HIV-infected and HIV-uninfected adults
    Durier, Christine
    Mercier-Delarue, Severine
    De Verdiere, Nathalie Colin
    Meiffredy, Vincent
    Matheron, Sophie
    Samri, Assia
    Resch, Martine
    Marchand, Lucie
    Autran, Brigitte
    Launay, Odile
    Simon, Francois
    AIDS, 2022, 36 (02) : 319 - 321
  • [6] Modelling the long-term persistence of neutralizing antibody in adults after one dose of live attenuated Japanese encephalitis chimeric virus vaccine
    Desai, Kamal
    Coudeville, L.
    Bailleux, F.
    VACCINE, 2012, 30 (15) : 2510 - 2515
  • [7] MODELING THE LONG-TERM NEUTRALIZING ANTIBODY PERSISTENCE IN ADULTS AFTER ONE DOSE OF LIVE ATTENUATED JAPANESE ENCEPHALITIS CHIMERIC VIRUS VACCINE
    Desai, Kamal
    Coudeville, Laurent
    Bailleux, Fabrice
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2010, 83 (05): : 313 - 314
  • [8] LONG DURATION OF NEUTRALIZING-ANTIBODY RESPONSE AFTER IMMUNIZATION OF MAN WITH A FORMALINIZED COLORADO TICK FEVER VACCINE
    THOMAS, LA
    PHILIP, RN
    PATZER, E
    CASPER, E
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1967, 16 (01): : 60 - &
  • [9] Antibody response 17D yellow fever vaccine in Ghanaian infants
    Osei-Kwasi, M
    Dunyo, SK
    Koram, KA
    Afari, EA
    Odoom, JK
    Nkrumah, FK
    BULLETIN OF THE WORLD HEALTH ORGANIZATION, 2001, 79 (11) : 1056 - 1059
  • [10] Durability of neutralizing antibodies against yellow fever virus after vaccination in healthy adults
    De Santis, Riccardo
    Faggioni, Giovanni
    Amoroso, Alessandra
    Ciammaruconi, Andrea
    Pomponi, Alice
    Lia, Maria Stella
    Amatore, Donatella
    Molinari, Filippo
    Petralito, Giancarlo
    Stefanelli, Paola
    Rezza, Giovanni
    Lista, Florigio
    VACCINE, 2023, 41 (17) : 2761 - 2763